Information on biocides
Information on biocides
Information on biocides
Il-prinċipju bażiku fir-Regolament dwar il-Prodotti Bijoċidali ((UE) Nru 528/2012 (BPR)) huwa li prodott bijoċidali għandu jiġi awtorizzat qabel ma jkun jista’ jitqiegħed fis-suq jew jintuża fiż-Żona Ekonomika Ewropea (ŻEE) u fl-Iżvizzera. Dan iseħħ f’żewġ stadji konsekuttivi. L-ewwel nett, is-sustanza attiva tiġi evalwata u, dment li jiġu ssodisfati l-kriterji, imbagħad tiġi approvata f’tip ta’ prodott speċifikat. It-tieni stadju huwa l-awtorizzazzjoni ta’ kull prodott li jikkonsisti fi, li jkun fih jew li jiġġenera s-sustanza(i) attiva(i) approvata(i). Din il-paġna tikkonċerna l-ewwel stadju.
Id-data f’din il-paġna hija ċċentrata fuq is-sustanza attiva/it-tip ta’ prodott. Dan huwa rifless fil-filtri tat-tiftix kollha u r-riżultati tat-tfittxijiet. Sussegwentement, it-tabella ta’ hawn taħt turi informazzjoni għal kull kombinazzjoni ta’ sustanza attiva/tip ta’ prodott. Għal raġunijiet ta’ effiċjenza, it-terminu sustanza attiva jintuża interkambjabbli mat-terminu ta’ kombinazzjoni ta’ sustanza attiva/tip ta’ prodott.
Il-bażi tad-data tinkludi sustanzi attivi fil-Programm ta’ Reviżjoni, sustanzi attivi mhux fil-Programm ta’ Reviżjoni kif ukoll sustanzi fl-Anness I għall-BPR. Aktar informazzjoni dwar il-kategorizzazzjoni ta’ sustanzi attivi tista’ tinqara fil-paġna Approvazzjoni ta’ sustanzi attivi.
Għal aktar informazzjoni dwar it-tfittxijiet li tista’ twettaq u kif l-informazzjoni hija ppreżentata jekk jogħġbok kompli aqra.
Kif għandek tfittex
Tista’ tara l-informazzjoni dwar is-sustanzi attivi bijoċidali b’żewġ modi:
- għal kull kombinazzjoni speċifika ta’ sustanza attiva u tip ta’ prodott (uża t-tab Fittex); u
- bħala sommarju tal-applikazzjonijiet kollha tat-tip ta’ prodott li ġew sottomessi għal sustanza attiva partikolari (tab tas-Sommarju).
Billi tuża t-tab Fittex, tista’ tfittex bi:
- Dettalji tas-sustanza attiva: identifikaturi tas-sustanza, tip ta’ prodott, kandidat għal sostituzzjoni.
(L-istatus prestabbilit għall-qasam Kandidat għal sostituzzjoni huwa “taħt valutazzjoni” u dan l-istatus mhux neċessarjament jimplika li s-sustanza attiva hija suspettata Kandidat għal sostituzzjoni. Sakemm is-sustanza attiva tkun identifikata jew le bħala kandidat potenzjali għal sostituzzjoni, l-istatus fuq il-paġna ta’ disseminazzjoni jinbidel kif meħtieġ għal “iva” jew “le”.)
- Data tal-approvazzjoni: pereżempju l-istatus ta’ applikazzjoni għall-approvazzjoni, l-istadju tal-valutazzjoni fil-proċess tal-approvazzjoni, il-validità tal-approvazzjoni mogħtija.
- Prodotti bijoċidali awtorizzati relatati (isem kummerċjali ta’ prodott bijoċidali).
Kif tiġi ppreżentata l-informazzjoni
It-tabella tar-riżultati tippreżenta informazzjoni dwar sustanza attiva, bħad-data tal-bidu u tat-tmiem tal-approvazzjoni, l-awtorità kompetenti tal-evalwazzjoni u l-istatus tal-approvazzjoni jew tal-valutazzjoni. L-isem tas-sustanza huwa link għall-paġna tal-informazzjoni dwar is-sustanza (Infocard) li tiġbor fil-qosor l-informazzjoni dwar sustanza mill-kuntesti regolatorji kollha ġestiti mill-ECHA.
Id-data dwar is-sustanzi attivi tinġabar mir-Reġistru għall-Prodotti Bijoċidali (R4BP 3). Din tkopri l-informazzjoni dwar is-sustanzi attivi li għalihom ġiet ippreżentata applikazzjoni għall-approvazzjoni għal tip ta’ prodott bijoċidali speċifiku skont il-BPR jew id-Direttiva dwar il-Prodotti Bijoċidali (id-Direttiva 98/8/KE). Jekk jogħġbok kun af li l-istadju ta’ validazzjoni f’R4BP 3 għandu jgħaddi b’suċċess biex is-sustanzi attivi jiġu diffużi jew biex jintwera l-istatus l-aktar reċenti fil-proċess tal-applikazzjoni.
Aktar informazzjoni dwar approvazzjoni ta’ sustanza attiva speċifika tista’ tinstab fl-iskeda informattiva (aċċessibbli permezz tal-ikona tal-għajn fit-tabella tar-riżultati). L-iskeda informattiva fiha dettalji dwar d-data tal-approvazzjoni l-aktar reċenti, inklużi d-dokumenti rilevanti, il-prodotti bijoċidali awtorizzati relatati, u ħarsa ġenerali lejn il-bidliet kollha dwar l-approvazzjoni tas-sustanza attiva.
Fit-tabella tar-riżultati, in-numru ta’ prodotti bijoċidali awtorizzati relatati huwa viżibbli wkoll. In-numru jirrappreżenta l-għadd ta’ raggruppamenti ta’ prodotti (gruppi ta’ awtorizzazzjonijiet) li fihom is-sustanza attiva partikolari.
It-tab tas-Sommarju telenka l-applikazzjonijiet kollha tat-tip ta’ prodott li ġew sottomessi għal sustanza attiva partikolari, irrispettivament minn jekk l-approvazzjoni ngħatatx jew ġiet rifjutata. L-istatus tal-approvazzjoni ta’ kombinazzjoni ta’ sustanza attiva u tip ta’ prodott huwa deskritt b’ikona. Meta tmexxi l-maws tiegħek fuq l-ikona, tista’ tara l-istatus ta’ applikazzjoni għall-approvazzjoni, l-istadju tal-valutazzjoni jekk il-proċess tal-approvazzjoni jkun għadu għaddej, u tista’ taċċessa l-iskeda informattiva tas-sustanza attiva.
Esporta r-riżultati
Tista’ tesporta r-riżultati tas-sustanza attiva lejn il-formati standard tas-sit web tal-ECHA (XLS, CSV u XML).
Due to a technical problem, which is being fixed, certain substance/product-type combinations are currently displayed with an inaccurate status.
Further information
- List of approved active substances
- Approval of active substances
- Understanding the BPR Regulation
- Q&A on Biocidal Products Regulation
- Give us your feedback
- BPC opinions on approval of active substances
- Public consultation on potential candidates for substitution
- Lists of Member States where wood treated with creosote may be placed on the market for certain uses [EN][PDF]
Note that the information is directly from the Member States
Last updated 06 Diċembru 2023. Database contains 938 active substance-product type and Annex I records for which approval has been sought.
| Annex I Substance (+)-Tartaric acid | 201-766-0 | 87-69-4 | 01/09/2013 |
- |
Approved | Link to the factsheet | 63 | ||
| (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclo-propanecarboxylate (d-Tetramethrin) | 214-619-0 | 1166-46-7 | PT18 icon PT18 |
Germany |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (13Z)-Hexadec-13-en-11-yn-1-yl acetate | 642-968-2 | 78617-58-0 | PT19 icon PT19 | 01/06/2023 | 31/05/2033 |
France |
Approved | Link to the factsheet | 1 |
| (2R,6aS,12aS)-1,2,6,6a,12,12a-hexa- hydro-2-isopropenyl-8,9-dimethoxychro- meno[3,4-b]furo[2,3-h]chromen-6-one (Rotenone) | 201-501-9 | 83-79-4 | PT17 icon PT17 |
United Kingdom |
Cancelled application | Link to the factsheet | |||
| (9Z,12E)-Tetradeca-9, 12-dien-1-yl acetate | 608-490-3 | 30507-70-1 | PT19 icon PT19 |
Austria |
No longer supported | Link to the factsheet | 12 | ||
| Annex I Substance (9Z,12E)-tetradeca-9,12-dien-1-yl acetate | 608-490-3 | 30507-70-1 | 01/09/2013 |
- |
Approved | Link to the factsheet | 18 | ||
| (benzothiazol-2-ylthio)methyl thiocyanate (TCMTB) | 244-445-0 | 21564-17-0 | PT09 icon PT09 |
Norway |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (benzothiazol-2-ylthio)methyl thiocyanate (TCMTB) | 244-445-0 | 21564-17-0 | PT12 icon PT12 |
Norway |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (benzyloxy)methanol | 238-588-8 | 14548-60-8 | PT06 icon PT06 |
Austria |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (benzyloxy)methanol | 238-588-8 | 14548-60-8 | PT13 icon PT13 |
United Kingdom |
No longer supported | Link to the factsheet | |||
| (E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3- methyl-2-nitroguanidine (Clothianidin) | 433-460-1 | 210880-92-5 | PT08 icon PT08 | 01/02/2010 | 31/01/2020 |
Germany |
Expired | Link to the factsheet | |
| (E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3- methyl-2-nitroguanidine (Clothianidin) | 433-460-1 | 210880-92-5 | PT18 icon PT18 | 01/10/2016 | 30/09/2026 |
Germany |
Approved | Link to the factsheet | 5 |
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) | 222-720-6 | 3586-55-8 | PT02 icon PT02 |
Poland |
No longer supported | Link to the factsheet | |||
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) | 222-720-6 | 3586-55-8 | PT06 icon PT06 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) | 222-720-6 | 3586-55-8 | PT11 icon PT11 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) | 222-720-6 | 3586-55-8 | PT12 icon PT12 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (ethylenedioxy)dimethanol (Reaction products of ethylene glycol with paraformaldehyde (EGForm)) | 222-720-6 | 3586-55-8 | PT13 icon PT13 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| (RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl (1R,3R)-2,2-dimethyl-3-(2-methyl- prop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3) (Esbiothrin) | 807-421-6 | 260359-57-7 | PT18 icon PT18 |
Germany |
Not approved | Link to the factsheet | |||
|
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl-(1R,3R; 1R,3S)-2,2-dimethyl-3-(2- methylprop-1-enyl)-cyclopropanecarboxy- late (mixture of 4 isomers 1R trans, 1R:1R trans, 1S: 1R cis, 1R: 1R cis,1S 4:4:1:1) (d-Allethrin) |
687-634-7 | 231937-89-6 | PT18 icon PT18 |
Germany |
Not approved | Link to the factsheet | |||
| (RS)-α-cyano-3phenoxybenzyl-(1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin) | 257-842-9 | 52315-07-8 | PT08 icon PT08 | 01/06/2015 | 31/05/2025 |
Belgium |
Approved | Link to the factsheet | 79 |
| (RS)-α-cyano-3phenoxybenzyl-(1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (Cypermethrin) | 257-842-9 | 52315-07-8 | PT18 icon PT18 | 01/06/2020 | 31/05/2030 |
Belgium |
Approved
-
Other updates in progress
- |
Link to the factsheet | 88 |
| 1,2-benzisothiazol-3(2H)-one (BIT) | 220-120-9 | 2634-33-5 | PT02 icon PT02 |
Spain |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) | 220-120-9 | 2634-33-5 | PT06 icon PT06 |
Spain |
Initial application for approval in progress
Commission decision |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) | 220-120-9 | 2634-33-5 | PT09 icon PT09 |
Spain |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) | 220-120-9 | 2634-33-5 | PT10 icon PT10 |
Spain |
No longer supported | Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) | 220-120-9 | 2634-33-5 | PT11 icon PT11 |
Spain |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) | 220-120-9 | 2634-33-5 | PT12 icon PT12 |
Spain |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 1,2-benzisothiazol-3(2H)-one (BIT) | 220-120-9 | 2634-33-5 | PT13 icon PT13 |
Spain |
Initial application for approval in progress
Commission decision |
Link to the factsheet | |||
| 1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) | 229-222-8 | 6440-58-0 | PT06 icon PT06 |
Poland |
Initial application for approval in progress
Opinion development by BPC |
Link to the factsheet | |||
| 1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) | 229-222-8 | 6440-58-0 | PT13 icon PT13 |
Poland |
Initial application for approval in progress
Opinion development by BPC |
Link to the factsheet | |||
| 1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl) urea (Hexaflumuron) | 401-400-1 | 86479-06-3 | PT18 icon PT18 | 01/04/2017 | 30/09/2024 |
Greece |
Approved
-
Renewal in progress
Competent authority evaluation |
Link to the factsheet | |
| 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (Imazalil) | 252-615-0 | 35554-44-0 | PT03 icon PT03 |
Germany |
No longer supported | Link to the factsheet | |||
| 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | 262-104-4 | 60207-90-1 | PT07 icon PT07 | 01/12/2016 | 30/11/2026 |
Finland |
Approved | Link to the factsheet | 1 |
| 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | 262-104-4 | 60207-90-1 | PT08 icon PT08 | 01/04/2010 | 30/11/2030 |
Finland |
Approved | Link to the factsheet | 962 |
| 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole) | 262-104-4 | 60207-90-1 | PT09 icon PT09 | 01/06/2015 | 31/05/2025 |
Finland |
Approved | Link to the factsheet | |
| 1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Empenthrin) | 259-154-4 | 54406-48-3 | PT18 icon PT18 |
Belgium |
Not approved | Link to the factsheet | |||
| 1R-trans phenothrin | 247-431-2 | 26046-85-5 | PT18 icon PT18 | 01/09/2015 | 31/08/2025 |
Ireland |
Approved | Link to the factsheet | 34 |
| 2,2-dibromo-2-cyanoacetamide (DBNPA) | 233-539-7 | 10222-01-2 | PT02 icon PT02 |
Denmark |
Cancelled application
-
Commission decision (participant withdrawal)
- |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) | 233-539-7 | 10222-01-2 | PT04 icon PT04 |
Denmark |
Initial application for approval in progress
Commission decision |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) | 233-539-7 | 10222-01-2 | PT06 icon PT06 |
Denmark |
Initial application for approval in progress
Commission decision |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) | 233-539-7 | 10222-01-2 | PT11 icon PT11 |
Denmark |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) | 233-539-7 | 10222-01-2 | PT12 icon PT12 |
Denmark |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2-dibromo-2-cyanoacetamide (DBNPA) | 233-539-7 | 10222-01-2 | PT13 icon PT13 |
Denmark |
No longer supported | Link to the factsheet | |||
| 2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) | 225-208-0 | 4719-04-4 | PT06 icon PT06 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) | 225-208-0 | 4719-04-4 | PT11 icon PT11 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) | 225-208-0 | 4719-04-4 | PT12 icon PT12 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2′,2′′-(hexahydro-1,3,5-triazine-1,3,5- triyl)triethanol (HHT) | 225-208-0 | 4719-04-4 | PT13 icon PT13 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2,2′-dithiobis[N-methylbenzamide] (DTBMA) | 219-768-5 | 2527-58-4 | PT06 icon PT06 |
Poland |
Initial application for approval in progress
Competent authority evaluation |
Link to the factsheet | |||
| 2-(2-butoxyethoxy)ethyl 6-propylpiper-onyl ether (Piperonyl butoxide/PBO) | 200-076-7 | 51-03-6 | PT18 icon PT18 | 01/07/2018 | 30/06/2028 |
Greece |
Approved | Link to the factsheet | 25 |
| 2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB) | 252-681-0 | 35691-65-7 | PT06 icon PT06 | 01/01/2018 | 31/12/2027 |
Czech Republic |
Approved | Link to the factsheet | |